Loxo Oncology to Announce Third Quarter 2018 Financial Results
November 01 2018 - 6:45AM
Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company
developing highly selective medicines for patients with genomically
defined cancers, will announce financial results for the third
quarter ended September 30, 2018 on November 8,
2018 before the Nasdaq market open. At 8:00 a.m.
ET that day, Loxo Oncology management will host a
conference call to discuss these financial results, in addition to
recent updates on development and corporate activities.
A live webcast can be accessed under "Events &
Presentations" in the Investors & Media section of the
company's website at www.loxooncology.com. The conference call
can be accessed by dialing (877) 930-8065 (domestic) or (253)
336-8041 (international) and referring to conference ID 8379404.
The webcast will be archived and made available for replay on the
company's website beginning approximately two hours after the
event.
About Loxo Oncology Loxo Oncology is
a biopharmaceutical company developing highly selective medicines
for patients with genomically defined cancers. Our pipeline focuses
on cancers that are uniquely dependent on single gene
abnormalities, such that a single drug has the potential to treat
the cancer with dramatic effect. We believe that the most
selective, purpose-built medicines have the highest probability of
maximally inhibiting the intended target, with the intention of
delivering best-in-class disease control and safety. Our management
team seeks out experienced industry partners, world-class
scientific advisors and innovative clinical-regulatory approaches
to deliver new cancer therapies to patients as quickly and
efficiently as possible. For more information, please visit the
company's website at www.loxooncology.com.
Contacts for Loxo Oncology, Inc.
Company: Lauren Cohen Director, Corporate Communications
lcohen@loxooncology.com
Investors: Peter Rahmer Endurance Advisors, LLC 415-515-9763
prahmer@enduranceadvisors.com
Media: Dan Budwick 1AB Media 973-271-6085 dan@1abmedia.com
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jun 2024 to Jul 2024
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jul 2023 to Jul 2024